European Journal of Chemistry

Determination of dimenhydrinate and cinnarizine in combined dosage form in presence of cinnarizine impurity

Main Article Content

Nada Sayed Abdelwahab
Maha Mohammed Abdelrahman
Fathy Mahmoud Salama
Amal Badawy Ahmed


Three accurate, sensitive and time saving spectrophotometric methods have been developed and validated for determination of mixture of dimenhydrinate (DMH) and cinnarizine (CIN) in presence of cinnarizine impurity (1-(diphenylmethyl)piperazine) (IMP). In method A; dimenhydrinate was determined by measuring 1D amplitudes at 292.0 nm while cinnarizine and its impurity were determined by 1DD method at 256.2 and 219.6 nm, respectively, using standard spectrum of 20 µg/mL of dimenhydrinate as a divisor. Method B depends on dividing spectrum of ternary mixture by standard spectrum of 20 µg/mL of dimenhydrinate and then cinnarizine and its impurity were determined in the obtained ratio spectrum by ratio difference method using the difference between 219.0 and 237.2 nm and between 230.0 and 264.0 nm, respectively. On the other hand dimenhydrinate could be determined by dividing spectrum of ternary mixture by standard spectrum of 20 µg/mL of cinnarizine and then it were determined at the obtained ratio spectrum by ratio difference method using the difference between 216.8 and 232.8 nm. Method C is the mean cantering of ratio spectra method (MCR) where the amplitudes at 234.8, 240.0 and 233.6 nm in the second mean centering ratio spectra were used for determination of dimenhydrinate, cinnarizine and its impurity, respectively. The developed methods were validated according to ICH guidelines regarding good accuracy and precision, and they were successfully applied to pharmaceutical formulation and laboratory prepared mixtures. The results were statistically compared with those obtained by reported method and no significant difference was found.

icon graph This Abstract was viewed 2146 times | icon graph Article PDF downloaded 850 times

How to Cite
Abdelwahab, N. S.; Abdelrahman, M. M.; Salama, F. M.; Ahmed, A. B. Determination of Dimenhydrinate and Cinnarizine in Combined Dosage Form in Presence of Cinnarizine Impurity. Eur. J. Chem. 2015, 6, 475-481.

Article Details

Crossref - Scopus - Google - European PMC

[1]. Budavaried, S. The Merck Index: An encyclopedia of chemicals, drugs and biological, 40th Ed., Merck & Co., Inc., Whitehouse Station, NJ, USA, 2006.

[2]. Profitt, K. Martindale, The extra Pharmacopeia: The complete drug reference, 35th Ed., Royal Pharmaceutical Society, London, UK, 2006.

[3]. British Pharmacopoeia, Vol. II, Stationary Office, Medicines and Health care Products Regulatory Agency, London, UK, 2010.

[4]. European Pharmacopoeia, 6th Edi., European Department for the Quality of Medicines within the Council of Europe, Strasbourg, France, 2008

[5]. The United States Pharmacopoeia, 32th revision, NF 27, The United States Pharmacopoeial Convention Inc., Rockville, MD, 2009.

[6]. Shah, P.B.; Patel, P. U. J. Pharm. Sci. Bio-Sci. Res. 2012, 2(2), 83-87.

[7]. Dalwadi, N.; Chhalotiya, U. K.; Shah, D.; Mehta, F.; Bhatt, K. Int. J. Adv. Pharm. Anal. 2014, 4(2), 58-61.

[8]. Patel, A. P.; Kadikar, H. K.; Shah, R. R.; Shukla, M. H.; Tank, P. K. Pharma Sci. Mon. Int. J. Pharm. Sci. 2012, 3(4), 2493-2505.

[9]. Lamie, N. T. Spectrochim. Acta A 2015, 141, 193-201.

[10]. El-Kafrawy, D. S.; Belal, T. S. J. Assoc. Arab Univ. Basic Appl. Sci. 2014, doi:10.1016/j.jaubas.2014.06.004.

[11]. Khushbu, S.; Pinkal, P. Int. J. Pharm. Sci. Res. 2014, 5(11), 4815-4819.

[12]. Lamie, N. T.; Monir, H. H. J. Chromatogr. Sci. 2015, doi:10.1093/chromsci/bmv103

[13]. International conference on the harmonization of technical requirements for the registration of pharmaceuticals for human use (ICH) Q2 (R1) Validation of Analytical Procedures: Text and Methodology. ICH Harmonized Tripartite Guideline, 2005.

Supporting Agencies

Most read articles by the same author(s)

Dimensions - Altmetric - scite_ - PlumX

Downloads and views


Download data is not yet available.


Metrics Loading ...
License Terms

License Terms


Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License ( By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License ( are administered by Atlanta Publishing House LLC (European Journal of Chemistry).